Nutex Health (NASDAQ:NUTX) Shares Gap Down - Time to Sell?

Nutex Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Nutex Health shares opened sharply lower, at $158.62 versus the prior close of $172.74, before last trading at about $164.78.
  • Analyst views remain generally positive: three analysts rate the stock Buy and two rate it Hold, for a “Moderate Buy” consensus and a $342 average price target.
  • The company beat quarterly earnings and revenue estimates, and announced a $2.00 special dividend payable December 14 to shareholders of record November 30.
  • Five stocks we like better than Nutex Health.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $172.74, but opened at $158.62. Nutex Health shares last traded at $164.7760, with a volume of 11,733 shares.

Analyst Ratings Changes

A number of analysts have commented on the stock. Wall Street Zen raised shares of Nutex Health from a "hold" rating to a "buy" rating in a research note on Saturday, November 14th. B. Riley Financial upped their target price on Nutex Health from $325.00 to $357.00 and gave the stock a "buy" rating in a research report on Monday, November 9th. Lake Street Capital lifted their price objective on shares of Nutex Health from $310.00 to $333.00 and gave the company a "buy" rating in a research note on Monday, November 9th. Weiss Ratings cut Nutex Health from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Thursday, November 12th. Finally, Ladenburg Thalmann & Co. Inc. initiated coverage on Nutex Health in a research note on Monday, October 26th. They issued a "buy" rating and a $336.00 price objective on the stock. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $342.00.

View Our Latest Analysis on NUTX

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.72 and a current ratio of 4.76. The firm has a 50 day moving average price of $200.34 and a two-hundred day moving average price of $152.42. The company has a market capitalization of $1.11 billion, a P/E ratio of 6.90 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $5.71 EPS for the quarter, beating the consensus estimate of $5.54 by $0.17. The company had revenue of $217.61 million for the quarter, compared to the consensus estimate of $214.82 million. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. On average, research analysts expect that Nutex Health Inc. will post 27.70 earnings per share for the current fiscal year.

Nutex Health Announces Dividend

The firm also recently disclosed a special dividend, which will be paid on Monday, December 14th. Shareholders of record on Monday, November 30th will be paid a $2.00 dividend. The ex-dividend date of this dividend is Monday, November 30th.

Insider Buying and Selling

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business's stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the transaction, the director directly owned 400 shares of the company's stock, valued at approximately $85,700. The trade was a 33.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 44.68% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Nutex Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. acquired a new position in Nutex Health in the second quarter valued at approximately $69,612,000. Winmill & CO. Inc. acquired a new position in Nutex Health in the 2nd quarter worth $11,168,000. Empowered Funds LLC acquired a new stake in Nutex Health in the 2nd quarter valued at approximately $7,720,000. Bank of New York Mellon Corp bought a new stake in shares of Nutex Health in the second quarter worth $3,956,000. Finally, Bridge City Capital LLC acquired a new position in shares of Nutex Health during the 3rd quarter worth about $3,918,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

(Get Free Report)

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company's chairman and chief executive officer, Nutex operates in the United States.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines